Latest News and Press Releases

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm

As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor

CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.

“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer

HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File...

HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research...

HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus...

HOUSTON, TX, May 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, announces the completion of the stage “research and...

HOUSTON, TX, April 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, today unveiled the rebranding of its identity, including...

HOUSTON, TX, April 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, has the pleasure to announce former football player,...